Inhibition of nitric oxide synthase evokes central sympatho-excitation in healthy humans

Journal of Physiology

Volumn 587, Issue 20, 2009, Pages 4977-4986

  Young, Colin N ^a,c   Fisher, James P ^a,c   Gallagher, Kevin M ^d   Whaley Connell, Adam ^a,c   Chaudhary, Kunal ^a,c   Victor, Ronald G ^e   Thomas, Gail D ^e   Fadel, Paul J ^a,b,c  

^a Department of Medical Pharmacology and Physiology ^*  (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d Austin Heart   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PHENYLEPHRINE;

ADULT; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MEASUREMENT; NORMAL HUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; SKIN; SYMPATHETIC NERVE; SYMPATHETIC TONE; TIME; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RESPONSE; EVOKED RESPONSE; HEART RATE; MEAN ARTERIAL PRESSURE; NERVE CONDUCTION; PRESSORECEPTOR; SKIN NERVE;

ADULT; BLOOD PRESSURE; CENTRAL NERVOUS SYSTEM; ENZYME INHIBITORS; FEMALE; HUMANS; HYPERTENSION; INFUSIONS, INTRAVENOUS; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SKIN; SYMPATHETIC NERVOUS SYSTEM;

EID: 70350624381     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2009.177204     Document Type: Article

References (67)

1. Augustyniak RA, Victor RG, Morgan DA, Zhang W. L-NAME- and ADMA-induced sympathetic neural activation in conscious rats. Am J Physiol Regul Integr Comp Physiol 2006, 290:R726-732.
2. Ayers NA, Kapas L, Krueger JM. The inhibitory effects of Nω-nitro-L-arginine methyl ester on nitric oxide synthase activity vary among brain regions in vivo but not in vitro. Neurochem Res 1997, 22:81-86.
3. Barman SM, Gebber GL. Subgroups of rostral ventrolateral medullary and caudal medullary raphe neurons based on patterns of relationship to sympathetic nerve discharge and axonal projections. J Neurophysiol 1997, 77:65-75.
4. Blottner D, Baumgarten HG. Nitric oxide synthetase (NOS)-containing sympathoadrenal cholinergic neurons of the rat IML-cell column: evidence from histochemistry, immunohistochemistry, and retrograde labelling. J Comp Neurol 1992, 316:45-55.
5. Branco LG, Carnio EC, Barros RC. Role of the nitric oxide pathway in hypoxia-induced hypothermia of rats. Am J Physiol Regul Integr Comp Physiol 1997, 273:R967-971.
6. Cardillo C, Panza JA. Impaired endothelial regulation of vascular tone in patients with systemic arterial hypertension. Vasc Med 1998, 3:138-144.
7. Chen CH, Shyr MH. Blockade of spinal nitric oxide synthase on blood pressure variability and hepatic microcirculation. Acta Anaesthesiol Taiwan 2005, 43:67-72.
8. Chowdhary S, Vaile JC, Fletcher J, Ross HF, Coote JH, Townend JN. Nitric oxide and cardiac autonomic control in humans. Hypertension 2000, 36:264-269.
9. Cogliati C, Magatelli R, Montano N, Narkiewicz K, Somers VK. Detection of low- and high-frequency rhythms in the variability of skin sympathetic nerve activity. Am J Physiol Heart Circ Physiol 2000, 278:H1256-1260.
10. Cui J, Sathishkumar M, Wilson TE, Shibasaki M, Davis SL, Crandall CG. Spectral characteristics of skin sympathetic nerve activity in heat-stressed humans. Am J Physiol Heart Circ Physiol 2006, 290:H1601-1609.
11. Cui J, Wilson TE, Crandall CG. Orthostatic challenge does not alter skin sympathetic nerve activity in heat-stressed humans. Auton Neurosci 2004, 116:54-61.
12. Dampney RA. Functional organization of central pathways regulating the cardiovascular system. Physiol Rev 1994, 74:323-364.
13. del Carmen Garcia M, Celuch SM, Adler-Graschinsky E. Possible participation of spinal nitric oxide in the control of the blood pressure in anaesthetized rats. Brain Res 1997, 764:67-74.
14. Delius W, Hagbarth KE, Hongell A, Wallin BG. Manoeuvres affecting sympathetic outflow in human skin nerves. Acta Physiologica Scandinavica 1972, 84:177-186.
15. Dun NJ, Dun SL, Forstermann U, Tseng LF. Nitric oxide synthase immunoreactivity in rat spinal cord. Neurosci Lett 1992, 147:217-220.
16. Dun NJ, Dun SL, Wu SY, Forstermann U, Schmidt HH, Tseng LF. Nitric oxide synthase immunoreactivity in the rat, mouse, cat and squirrel monkey spinal cord. Neuroscience 1993, 54:845-857.
17. Dwyer MA, Bredt DS, Snyder SH. Nitric oxide synthase: irreversible inhibition by L-NG-nitroarginine in brain in vitro and in vivo. Biochem Biophys Res Commun 1991, 176:1136-1141.
18. Fisher JP, Young CN, Fadel PJ. Central sympathetic overactivity: maladies and mechanisms. Auton Neurosci 2009, 148:5-15.
19. Fong AY, Talman WT, Lawrence AJ. Axonal transport of NADPH-diaphorase and [3H]nitro-L-arginine binding, but not [3H]cGMP binding, by the rat vagus nerve. Brain Res 2000, 878:240-246.
20. Grassi G. Counteracting the sympathetic nervous system in essential hypertension. Curr Opin Nephrol Hypertens 2004, 13:513-519.
21. Hagbarth KE, Hallin RG, Hongell A, Torebjork HE, Wallin BG. General characteristics of sympathetic activity in human skin nerves. Acta Physiologica Scandinavica 1972, 84:164-176.
22. Hakim MA, Hirooka Y, Coleman MJ, Bennett MR, Dampney RA. Evidence for a critical role of nitric oxide in the tonic excitation of rabbit renal sympathetic preganglionic neurones. J Physiol 1995, 482:401-407.
23. Hansen J, Jacobsen TN, Victor RG. Is nitric oxide involved in the tonic inhibition of central sympathetic outflow in humans?. Hypertension 1994, 24:439-444.
24. Heinzel B, John M, Klatt P, Bohme E, Mayer B. Ca2+/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase. Biochem J 1992, 281:627-630.
25. Herring N, Paterson DJ. Neuromodulators of peripheral cardiac sympatho-vagal balance. Exp Physiol 2009, 94:46-53.
26. Iadecola C, Xu X, Zhang F, Hu J, el-Fakahany EE. Prolonged inhibition of brain nitric oxide synthase by short-term systemic administration of nitro-L-arginine methyl ester. Neurochem Res 1994, 19:501-505.
27. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005, 365:217-223.
28. Koga N, Takano Y, Honda K, Saito R, Kamiya H. Roles of nitric oxide in the spinal cord in cardiovascular regulation in rats. Neurosci Lett 1999, 267:173-176.
29. Korner PI. Essential Hypertension and its Causes: Neural and Non-Neural Mechanisms 2007, Oxford University Press, New York
30. Lepori M, Sartori C, Trueb L, Owlya R, Nicod P, Scherrer U. Haemodynamic and sympathetic effects of inhibition of nitric oxide synthase by systemic infusion of NG-monomethyl-L-arginine into humans are dose dependent. J Hypertens 1998, 16:519-523.
31. Lu PP, Shee JJ, Chen HM, Lin CC, Shyr MH. Spinal nitric oxide participates in the control of the blood pressure during graded hemorrhage in the conscious rat. Shock 1999, 12:222-226.
32. Macefield VG, Wallin BG. Respiratory and cardiac modulation of single sympathetic vasoconstrictor and sudomotor neurones to human skin. J Physiol 1999, 516:303-314.
33. Menon DV, Wang Z, Fadel PJ, Arbique D, Leonard D, Li JL, Victor RG, Vongpatanasin W. Central sympatholysis as a novel countermeasure for cocaine-induced sympathetic activation and vasoconstriction in humans. J Am College Cardiol 2007, 50:626-633.
34. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993, 329:2002-2012.
35. Morrison SF. Differential control of sympathetic outflow. Am J Physiol Regul Integr Comp Physiol 2001, 281:R683-698.
36. Narkiewicz K, van de Borne PJ, Hausberg M, Cooley RL, Winniford MD, Davison DE, Somers VK. Cigarette smoking increases sympathetic outflow in humans. Circulation 1998, 98:528-534.
37. Owlya R, Vollenweider L, Trueb L, Sartori C, Lepori M, Nicod P, Scherrer U. Cardiovascular and sympathetic effects of nitric oxide inhibition at rest and during static exercise in humans. Circulation 1997, 96:3897-3903.
38. Palacios M, Knowles RG, Palmer RM, Moncada S. Nitric oxide from L-arginine stimulates the soluble guanylate cyclase in adrenal glands. Biochem Biophys Res Commun 1989, 165:802-809.
39. Rafalzik S, Pehl U, Ott D, Strotmann J, Wolff M, Gerstberger R. Cholinergic signal transduction in the mouse sphenopalatine ganglion. Brain Res 2008, 1241:42-55.
40. Rodrigo J, Springall DR, Uttenthal O, Bentura ML, Abadia-Molina F, Riveros-Moreno V, Martinez-Murillo R, Polak JM, Moncada S. Localization of nitric oxide synthase in the adult rat brain. Philos Trans R Soc Lond B Biol Sci 1994, 345:175-221.
41. Sakuma I, Togashi H, Yoshioka M, Saito H, Yanagida M, Tamura M, Kobayashi T, Yasuda H, Gross SS, Levi R. NG-methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo. A role for nitric oxide in the central regulation of sympathetic tone?. Circ Res 1992, 70:607-611.
42. Salter M, Duffy C, Garthwaite J, Strijbos PJ. Substantial regional and hemispheric differences in brain nitric oxide synthase (NOS) inhibition following intracerebroventricular administration of Nω-nitro-L-arginine (L-NA) and its methyl ester (L-NAME). Neuropharmacology 1995, 34:639-649.
43. Sander M, Chavoshan B, Victor RG. A large blood pressure-raising effect of nitric oxide synthase inhibition in humans. Hypertension 1999, 33:937-942.
44. Sander M, Hansen J, Victor RG. The sympathetic nervous system is involved in the maintenance but not initiation of the hypertension induced by Nω-nitro-L-arginine methyl ester. Hypertension 1997, 30:64-70.
45. Sander M, Hansen PG, Victor RG. Sympathetically mediated hypertension caused by chronic inhibition of nitric oxide. Hypertension 1995, 26:691-695.
46. Sander M, Victor RG. Neural mechanisms in nitric oxide-deficient hypertension. Curr Opin Nephrol Hypertens 1999, 8:61-73.
47. Scammell TE, Elmquist JK, Saper CB. Inhibition of nitric oxide synthase produces hypothermia and depresses lipopolysaccharide fever. Am J Physiol Regul Integr Comp Physiol 1996, 271:R333-338.
48. Spieker LE, Corti R, Binggeli C, Luscher TF, Noll G. Baroreceptor dysfunction induced by nitric oxide synthase inhibition in humans. J Am College Cardiol 2000, 36:213-218.
49. Steiner AA, Carnio EC, Antunes-Rodrigues J, Branco LG. Role of nitric oxide in systemic vasopressin-induced hypothermia. Am J Physiol Regul Integr Comp Physiol 1998, 275:R937-941.
50. Takeuchi S, Iwase S, Mano T, Okada H, Sugiyama Y, Watanabe T. Sleep-related changes in human muscle and skin sympathetic nerve activities. J Auton Nerv Syst 1994, 47:121-129.
51. Thomas GD, Zhang W, Victor RG. Nitric oxide deficiency as a cause of clinical hypertension: promising new drug targets for refractory hypertension. JAMA 2001, 285:2055-2057.
52. Traystman RJ, Moore LE, Helfaer MA, Davis S, Banasiak K, Williams M, Hurn PD. Nitro-L-arginine analogues. Dose- and time-related nitric oxide synthase inhibition in brain. Stroke 1995, 26:864-869.
53. Vallbo AB, Hagbarth KE, Torebjork HE, Wallin BG. Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves. Physiol Rev 1979, 59:919-957.
54. Vissing SF, Scherrer U, Victor RG. Stimulation of skin sympathetic nerve discharge by central command. Differential control of sympathetic outflow to skin and skeletal muscle during static exercise. Circ Res 1991, 69:228-238.
55. Vongpatanasin W, Mansour Y, Chavoshan B, Arbique D, Victor RG. Cocaine stimulates the human cardiovascular system via a central mechanism of action. Circulation 1999, 100:497-502.
56. Wallin BG, Sundlof G, Delius W. The effect of carotid sinus nerve stimulation on muscle and skin nerve sympathetic activity in man. Pflugers Arch 1975, 358:101-110.
57. Wilson TE, Cui J, Crandall CG. Absence of arterial baroreflex modulation of skin sympathetic activity and sweat rate during whole-body heating in humans. J Physiol 2001, 536:615-623.
58. Wilson TE, Dyckman DJ, Ray CA. Determinants of skin sympathetic nerve responses to isometric exercise. J Appl Physiol 2006, 100:1043-1048.
59. Wilson TE, Kuipers NT, McHugh EA, Ray CA. Vestibular activation does not influence skin sympathetic nerve responses during whole body heating. J Appl Physiol 2004, 97:540-544.
60. Wu SY, Dun NJ. Calcium-activated release of nitric oxide potentiates excitatory synaptic potentials in immature rat sympathetic preganglionic neurons. J Neurophysiol 1995, 74:2600-2603.
61. Wu SY, Dun NJ. Potentiation of IPSCs by nitric oxide in immature rat sympathetic preganglionic neurones in vitro. J Physiol 1996, 495:479-490.
62. Wu SY, Dun SL, Forstermann U, Dun NJ. Nitric oxide and excitatory postsynaptic currents in immature rat sympathetic preganglionic neurons in vitro. Neuroscience 1997, 79:237-245.
63. Young CN, Keller DM, Crandall CG, Fadel PJ. Comparing resting skin sympathetic nerve activity between groups: caution needed. J Appl Physiol 2009, 106:1751-1752. author reply 1753
64. Zanzinger J, Czachurski J, Seller H. Inhibition of basal and reflex-mediated sympathetic activity in the RVLM by nitric oxide. Am J Physiol Regul Integr Comp Physiol 1995, 268:R958-962.
65. Zhang K, Patel KP. Effect of nitric oxide within the paraventricular nucleus on renal sympathetic nerve discharge: role of GABA. Am J Physiol Regul Integr Comp Physiol 1998, 275:R728-734.
66. Zucker IH, Liu JL. Angiotensin II-nitric oxide interactions in the control of sympathetic outflow in heart failure. Heart Fail Rev 2000, 5:27-43.
67. Zucker IH, Schultz HD, Li YF, Wang Y, Wang W, Patel KP. The origin of sympathetic outflow in heart failure: the roles of angiotensin II and nitric oxide. Progr Biophys Mol Biol 2004, 84:217-232.